Injection technique that actually matters Beyond choosing a site and rotating properly, the way you physically perform the injection has a meaningful impact on comfort, absorption, and complication risk
After 72 weeks, average weight loss was 16.0% at 5mg, 21.4% at 10mg, and 22.5% at 15mg
While these results are promising, we should approach them with measured optimism
If you want more support while you are managing appetite changes during treatment, our GLP-1 Daily Support supplement is designed for that kind of day-to-day nutritional routine
The HD formulation is specifically suited to: Plateau patients: Those who responded to 2.4 mg but stalled before reaching weight goal Patients seeking maximum semaglutide efficacy: Where the additional dose escalation justifies the higher side effect risk Tirzepatide-intolerant patients: Who responded to GLP-1 monotherapy but did not tolerate the GIP component of tirzepatide Patients still in the early titration phase of standard Wegovy should generally complete a full trial at 2.4 mg before escalating
Theranostics 12 , 14191439 (2022)